Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Journal of Medicinal Chemistry|August 20, 2015
Pharmaceutical Optimization of Peptide Toxins for Ion Channel Targets: Potent, Selective, and Long-Lived Antagonists of Kv1.3Justin K Murray, Yi-Xin Qian, Benxian Liu, et al.
Journal of Medicinal Chemistry|December 4, 2003
Synthesis and evaluation of imidazole acetic acid inhibitors of activated thrombin-activatable fibrinolysis inhibitor as novel antithromboticsJames C Barrow, Philippe G Nantermet, Shaun R Stauffer, et al.
Journal of Medicinal Chemistry|January 15, 2015
Discovery of 1H-pyrazol-3(2H)-ones as potent and selective inhibitors of protein kinase R-like endoplasmic reticulum kinase (PERK)Adrian L Smith, Kristin L Andrews, Holger Beckmann, et al.
Journal of Medicinal Chemistry|July 11, 2022
Identification of a Potent, Selective, and Brain-Penetrant Rho Kinase Inhibitor and its Activity in a Mouse Model of Huntington's DiseaseTammy Ladduwahetty, Matthew R Lee, Michel C Maillard, et al.
Journal of Medicinal Chemistry|March 30, 2021
Structure-Based Exploration of Selectivity for ATM Inhibitors in Huntington's DiseaseAmanda Van de Poël, Leticia Toledo-Sherman, Perla Breccia, et al.
Journal of Medicinal Chemistry|March 7, 2019
Optimization of Potent and Selective Ataxia Telangiectasia-Mutated Inhibitors Suitable for a Proof-of-Concept Study in Huntington's Disease ModelsLeticia Toledo-Sherman, Perla Breccia, Roger Cachope, et al.
Frontiers in Genome Editing|December 22, 2025
Development of efficient targeted insertion mediated by CRISPR-Cas12a and homology-directed repair in maizeBrenden Barco, Shujie Dong, Yuki Matsuba, et al.
Bioanalysis|December 24, 2014
2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 3 - LBA and immunogenicity)Lauren Stevenson, Lakshmi Amaravadi, Heather Myler, et al.
Pageof 5